Fig. 1From: Clinical translation of patient-derived tumour organoids- bottlenecks and strategiesComparison of Cell Lines, Patient-Derived Xenografts (PDXs) and Patient-Derived Tumour Organoids (PDTOs). A: 2D cell line model; B: Patient-Derived Xenografts (PDXs) model; C: Patient-Derived Tumour Organoids (PDTOs) modelBack to article page